Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Hepatocellular × Watchful Waiting × 30 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 4 Prostatic Neoplasms 3 Oropharyngeal Neoplasms 2 Lung Neoplasms 2 Carcinoma, Renal Cell 2 Ureteral Neoplasms 1 Triple Negative Breast Neoplasms 1 Stage I Mixed Cell Type Kidney Wilms Tumor 1 Retinoblastoma 1 Pleuropulmonary blastoma 1 Pelvic Neoplasms 1 Nasopharyngeal Carcinoma 1 Mouth Neoplasms 1 Melanoma 1 Lymphoma, Mantle-Cell 1 Leukemia, Myeloid, Acute 1 Epstein-Barr Virus Infections 1 Burkitt Lymphoma 1 Breast Neoplasms 1 Breast Carcinoma In Situ 1 Anus Neoplasms 1 Anatomic Stage I Breast Cancer AJCC v8 1 Anal Canal Carcinoma 1

Interventions

Bevacizumab 13 atezolizumab 12 Specimen Handling 9 Nivolumab 8 durvalumab 6 pembrolizumab 4 X-Rays 4 Radiosurgery 4 Magnetic Resonance Spectroscopy 4 Ipilimumab 4 lenvatinib 3 Sorafenib 3 Immunoglobulin G 3 E-7386 3 Cyclophosphamide 3 Blood Specimen Collection 3 sintilimab 2 regorafenib 2 cabozantinib 2 Disulfides 2 Biopsy 2 tremelimumab 1 tislelizumab 1 sofosbuvir-velpatasvir drug combination 1 sargramostim 1 sapanisertib 1 rocakinogene sifuplasmid 1 relatlimab 1 recombinant interferon alpha 2b-like protein 1 fludarabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡